|
|
13-01 Pollitt Drive
Extension Fair Lawn, NJ 07410 USA
phone:201-703-2299
fax:
|
|
| Symbol |
VYTR.OB |
| Exchange |
OBB |
| Founded |
2000 |
| Employees |
|
|
|
| www.vyteris.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Active patch drug delivery using proprietary technology. |
|
| Management |
| Eugene Bauer, M.D. - Chairman of the Board; Haro Hartounian, Ph.D. - President & Chief Executive Officer;
Joseph Himy - Chief Financial Officer, CPA; Michael Reidy, Ph.D. - Vice President, Research and Development; Cormac H. Lyons, Ph.D. - Vice President, Product and Process Development Engineering |
| |
|
|
|
|
|
|
|
|
|
|
|
| Description |
|
Developer of the first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. It's proprietary active transdermal drug delivery (iontophoresis) technology, smart patch, delivers drugs comfortably through the skin using low-level electrical energy. This active patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. |
|
| Products / Services |
Lidosite(R)
|
|
| Technology / Differentiation |
| Smart Patch Technology, |
|
|
| Status |
| Clinical programs in migraine and infertility
Preclinical programs in pain management, osteoporosis, migraine and diabetes
Market cap: $31.2
Share price: $0.50
Shares outstanding: 62.4MM
Float: 6.02MM
Cash: $222K |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members